rs121908381

Variant summary

Our verdict is Pathogenic. The variant received 19 ACMG points: 20P and 1B. PVS1PS3PP5_Very_StrongBS2_Supporting

The NM_001048174.2(MUTYH):​c.1354G>T​(p.Glu452*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,614,088 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000731994: "In vitro functional studies provide support that the p.Glu480X variant impacts protein activity" (Ali 2008 PMID:18534194)." and additional evidence is available in ClinVar. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000043 ( 2 hom. )

Consequence

MUTYH
NM_001048174.2 stop_gained

Scores

5
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:21O:1

Conservation

PhyloP100: 7.31

Publications

37 publications found
Variant links:
Genes affected
MUTYH (HGNC:7527): (mutY DNA glycosylase) This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017]
MUTYH Gene-Disease associations (from GenCC):
  • familial adenomatous polyposis 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, G2P, Orphanet
  • colorectal cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 19 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PS3
PS3 evidence extracted from ClinVar submissions: SCV000731994: "In vitro functional studies provide support that the p.Glu480X variant impacts protein activity" (Ali 2008 PMID: 18534194).; SCV000915413: Functional data from Ali et al. (2008) showed that the p.Glu466Ter variant protein had dysfunctional glycosylase and DNA binding activity compared with wild type protein.; SCV001134994: An experimental study suggests that the variant results in defective glycosylase and DNA-binding activity.; SCV001337823: The truncated protein product had lost its glycosylase- and DNA binding activity (Ali_2008).; SCV004829862: A functional study has shown that the truncated mutant protein is expressed at low levels in E. coli and exhibits lack of glycosylase activity and DNA-binding activity (PMID: 18534194).; SCV005042840: An experimental study suggests that the variant results in defective glycosylase and DNA-binding activity (Ali M, et. al., 2008).; SCV000273045: an in vitro functional study demonstrated that the E480* mutant protein was completely devoid of both glycosylase and DNA-binding activities, both of which are essential for the base excision repair properties of the wild-type MUTYH protein (Ali M et al. Gastroenterology. 2008 Aug;135:499-507).; SCV000685579: A functional study has shown that the truncated mutant protein is expressed at low levels in E. coli and exhibits lack of glycosylase activity and DNA-binding activity (PMID: 18534194).; SCV000293493: Published functional studies demonstrate a damaging effect: defective glycosylase and DNA binding activities (Ali 2008); PMID: 25590978, 19032956, 26202870, 27194394, 26902849, 23035301, 18534194, 33130102, 32411090, 19732775, 12393807, 12853198, 17369389, 15635083, 17874208, 28533537, 28790112, 28381238, 27631816, 30609409, 30604180; SCV000592719: a functional study demonstrated that this variant led to absent glycosylase and no DNA binding activity (Ali 2008).; SCV004046165: Functional studies showed that the c.1429G>T (p.Glu477Ter) variant alters the function of the MUTYH protein (PMID: 18534194).
PP5
Variant 1-45331220-C-A is Pathogenic according to our data. Variant chr1-45331220-C-A is described in ClinVar as Pathogenic. ClinVar VariationId is 5297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001048174.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUTYH
NM_001128425.2
MANE Plus Clinical
c.1438G>Tp.Glu480*
stop_gained
Exon 14 of 16NP_001121897.1E5KP25
MUTYH
NM_001048174.2
MANE Select
c.1354G>Tp.Glu452*
stop_gained
Exon 14 of 16NP_001041639.1Q9UIF7-6
MUTYH
NM_012222.3
c.1429G>Tp.Glu477*
stop_gained
Exon 14 of 16NP_036354.1Q9UIF7-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUTYH
ENST00000710952.2
MANE Plus Clinical
c.1438G>Tp.Glu480*
stop_gained
Exon 14 of 16ENSP00000518552.2E5KP25
MUTYH
ENST00000456914.7
TSL:1 MANE Select
c.1354G>Tp.Glu452*
stop_gained
Exon 14 of 16ENSP00000407590.2Q9UIF7-6
MUTYH
ENST00000372098.7
TSL:1
c.1429G>Tp.Glu477*
stop_gained
Exon 14 of 16ENSP00000361170.3Q9UIF7-1

Frequencies

GnomAD3 genomes
AF:
0.0000657
AC:
10
AN:
152212
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000517
AC:
13
AN:
251492
AF XY:
0.0000589
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000431
AC:
63
AN:
1461758
Hom.:
2
Cov.:
32
AF XY:
0.0000509
AC XY:
37
AN XY:
727162
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000684
AC:
59
AN:
86226
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111932
Other (OTH)
AF:
0.0000662
AC:
4
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000656
AC:
10
AN:
152330
Hom.:
0
Cov.:
33
AF XY:
0.0000537
AC XY:
4
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41576
American (AMR)
AF:
0.00
AC:
0
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000168
Hom.:
0
Bravo
AF:
0.0000189
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000988
AC:
12

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
12
-
-
Familial adenomatous polyposis 2 (13)
3
-
-
Hereditary cancer-predisposing syndrome (3)
3
-
-
not provided (3)
1
-
-
Carcinoma of colon (1)
1
-
-
Gastric cancer;C3272841:Familial adenomatous polyposis 2 (1)
1
-
-
MUTYH-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.66
CADD
Pathogenic
38
DANN
Uncertain
1.0
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.91
FATHMM_MKL
Pathogenic
1.0
D
PhyloP100
7.3
Vest4
0.58
ClinPred
0.78
D
GERP RS
5.2
Mutation Taster
=2/198
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908381; hg19: chr1-45796892; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.